Charting the structure-sequence landscape of light chain amyloids
Gabriele Orlando1,2, Rodrigo Gallardo1,2, Alicia Colla1,2
1Switch Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, 3000, Belgium.
Motivation:
Light chain amyloidosis is a disease where misfolded antibody light chains (LCs) form toxic amyloid fibrils, leading to organ damage. Although LC overproduction occurs in all cases, only certain individuals develop the disease, suggesting that specific LC sequences and properties drive amyloid formation. This process is complex, involving both protein sequence and environmental factors, but mutations that destabilize the LC fold are linked to amyloid aggregation. Despite the significance of the disease, our understanding of LC fibril formation remains limited due to the lack of extensive data and technical challenges in studying amyloid structures. To address this, a tool is needed to compare unknown LC sequences with known structures and predict which amyloids are likely to adopt new conformations, guiding experimental investigations.
Results:
HMMSTUFF addresses this by using a Hidden Markov Model to generate similarity scores between LC sequences and existing PDB templates, eventually modeling the LC amyloid structures similar enough to known templates. HMMSTUFF on one side expands our understanding of LC amyloid fibril conformations, and on the other highlights the gaps in our current knowledge of LC structural space.
Availability And Implementation:
HMMSTUFF is available as pypi package and as source code at https://github.com/grogdrinker/hmmstuff.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Protein Organization
Protein Folding
Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme...
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...


